Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

WHO approves world's first malaria vaccine
Malaria is a leading cause of childhood illness and death in sub-Saharan Africa.
Pilot study led to a 30 per cent reduction in severe malaria in parts of Africa.

The World Health Organization (WHO) has recommended the use of a malaria vaccine among children in countries with moderate to high transmission of the disease.

The recommendation of the RTS, S malaria vaccine is the result of an ongoing pilot study taking place in Ghana, Kenya and Malawi, which has reached more than 800,000 children since 2019.

WHO director-general Dr Tedros Adhanom Ghebreyesus dubbed the long-awaited vaccine as a “historic moment” and that it “could save thousands of young lives each year”.

Spread by the P.falciparum parasite, malaria is a leading cause of childhood illness and death in sub-Saharan Africa; every year the disease kills more than 260,000 children in the region aged under five. 

In recent years, however, the WHO and partners have been reporting a stagnation in progress against the disease.

Dr Matshidiso Moeti, WHO regional director for Africa, commented: "For centuries, malaria has stalked sub-Saharan Africa, causing immense personal suffering. We have long hoped for an effective malaria vaccine, and now for the first time ever, we have such a vaccine recommended for widespread use.”

To date, more than 2.3 million doses of the RTS, S vaccine, developed by GSK, have already been administered as part of the pilot study. Key findings show that the vaccine is feasible to deliver, safe and cost-effective, even in areas with high malaria transmission. 

In the countries where the vaccine was administered, there was a 30 per cent fall in deadly severe malaria, even where malaria nets are used and there is good access to diagnosis and treatment. 

Dr Tedros said: “This is a historic moment. The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control. Using this vaccine on top of existing tools to prevent malaria could save tens of thousands of young lives each year.” 

Later this year, Gavi, the Vaccine Alliance is expected to consider financing a broader vaccine rollout across Africa. The WHO will also work with regional health organisations about whether to adopt the vaccine as part of national malaria control strategies.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.